ZTS (Zoetis Inc) Earnings per share for the trailing year

Public company logo of Zoetis Corporation (ZTS)

Risks of reduced owner spending on expensive treatments remain contained. YoY TTM net income per share growth visualizes current resilience, where the value of -0.80 shows the latest figure. Zoetis Inc. (ZTS) leverages its veterinary dominance through large-scale R&D investments. The positive trend is based on the humanization of pets and the introduction of innovative arthritis medications.

ZTS Zoetis Inc: Earnings per share for the last twelve months in the range 02/11/2024 - 11/17/2026

Financial and market metric breakdowns for zoetis.com (ZTS)

- market price and analyst price targets:
- business market valuation indicators:
Fundamental valuation:Zoetis Corp
Manufactured product of Zoetis Inc.

To build a portfolio of high-quality assets, I evaluate the dynamics of real business returns. This indicator measures the percentage change in rolling net income per share over the last 12 months relative to the same period last year. For Zoetis Inc. (ZTS), such a model reflects the synergy between the companion and livestock animal markets, maintaining the indicator at -0.80. By analyzing the EPS YoY ttm chart, an investor can promptly detect a slowdown in the company's expansion.